Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.
Clinical fit
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Exact purpose
Pre-procedural cardiovascular anatomy assessment, measurement, visualization, sizing, and planning support for transcatheter aortic valve replacement.
FDA source Exact FDA submission Checked 2026-09-08
AI-assisted segmentation, reconstruction, landmark detection, multiplanar reformats, measurement, TAVR sizing, reporting, and C-arm planning support with user review and manual measurement available; not a stand-alone decision tool
FDA source Exact FDA submission Checked 2026-09-08
Vendor-independent CT data in DICOM format for patients with tricuspid aortic stenosis who are eligible for TAVR and have no prior aortic-valve implant.
FDA source Exact FDA submission Checked 2026-09-08
Automatic full-heart and vessel segmentation; 2D/3D rendering; centerline and TAVR-plane detection; MPR; cardiac and aortic measurements; S-curve/C-arm angulation; downloadable 3D meshes; IFU-based TAVR sizing chart; and downloadable PDF or DICOM PDF reports.
FDA source Exact FDA submission Checked 2026-09-08
The indication is limited to patients with tricuspid aortic stenosis who are eligible for TAVR and have no prior aortic-valve implant. The software is not intended to be a decision-making tool by itself. Validation was technical measurement comparison and repeatability/usability testing, not a clinical-outcome study.
FDA source Exact FDA submission Checked 2026-09-08
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
FDA submission
K241984
FDA source Exact FDA submission Checked 2026-08-31
Use these fields to structure a vendor demo, security review, and implementation estimate.
Integration
Cloud-based SaMD in which users upload DICOM CT images and receive automated measurements, 2D/3D visualizations, and PDF/DICOM PDF reports; the FDA packet does not establish a specific local PACS, RIS, or EHR interface.
FDA source Exact FDA submission Checked 2026-09-08
Public source Exact FDA submission Checked 2026-08-13
Deployment category preserved from the prior exact-submission review; hosting region, data flow, and current commercial configuration still require vendor confirmation.
ACR AI Central provides an exact-submission model card for Hi-D Imaging 4TAVR; FDA labeling remains controlling for clinical use, limitations, and performance.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.
Evidence summary
FDA packet: five technical validation studies covering 929 CT scans of TAVR-eligible patients without a prior aortic-position implant, including 289 U.S. and 640 European scans, compared automated measurements with expert ground truth. Annulus-parameter agreement exceeded 98% in U.S. studies and 97% in European studies; repeatability used 100 cases, and usability used 15 intended users across 105 scenarios.
FDA source Exact FDA submission Checked 2026-09-08
Needs research Exact FDA submission Checked 2026-08-31
This field has not been curated yet.
Reported specificity
Research pending
Needs research Exact FDA submission Checked 2026-08-31
This field has not been curated yet.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Hi-D Imaging 4TAVR regulatory performance study summary
Stand-Alone Performance · Adult
exact submission · Tested version: Exact product version not reported; regulatory study summarized for FDA submission K241984 · n=929 · 5 sites · Independence not established
K241984
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
These are common procurement questions; unknown values remain visible until a source supports them.
Pricing and total cost
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-08
No public price or quote for the exact K241984 configuration was established in this review.
Reimbursement and coding
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-08
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K241984. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
Public source Exact FDA submission Checked 2026-09-08
Verify security and privacy controls: Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Verify training: Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Verify pricing and total cost: No public price or quote for the exact K241984 configuration was established in this review.
Verify reimbursement and coding relevance: No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Verify local validation and lifecycle monitoring: Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-08Last searched
23Fields reviewed
9Source classes checked
0Unreviewed PubMed leads
0Unreviewed trial leads
0Unreviewed FDA recall leads
Exact-submission ACR model-card fields were normalized under the current provenance rules; vendor and independent-study confirmation remain distinct. Exact FDA scope controls clinical claims. ACR provides bounded exact-submission catalog context. Candidate literature metadata remains a discovery queue until full-text identity, endpoint, population, and version review is completed. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads remain unpublished until a human confirms the exact product and tested version.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
AI-CVD provides automated quantitative CT-derived anatomical and density measurements for clinician review, including calcium scores, cardiac and vascular measurements, lung and...
cvi42 Coronary Plaque supports qualified professionals with viewing, post-processing, and qualitative and quantitative evaluation of adult cardiac CT DICOM images to assess the...